Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases

American Journal of Hypertension

Volumn 17, Issue 5, 2004, Pages 415-420

  Seeman, Tomáš ^a,c   Dušek, Jiří ^a   Vondrák, Karel ^a   Flögelová, Hana ^b   Geier, Pavel ^b   Janda, Jan ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Ambulatory blood pressure monitoring; Children; Hypertension; Proteinuria; Ramipril

Indexed keywords

RAMIPRIL;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CORRELATION ANALYSIS; COUGHING; DIZZINESS; DRUG ERUPTION; DRUG TOLERANCE; EDEMA; FATIGUE; FEMALE; GLOMERULUS FILTRATION; HUMAN; HYPERTENSION; MALE; MONOTHERAPY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEINURIA; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHILD; CHILD WELFARE; CHILD, PRESCHOOL; CHRONIC DISEASE; CIRCADIAN RHYTHM; DIASTOLE; FEMALE; HUMANS; HYPERTENSION; INFANT; KIDNEY DISEASES; MALE; PROSPECTIVE STUDIES; PROTEINURIA; RAMIPRIL; SEVERITY OF ILLNESS INDEX; STATISTICS; SYSTOLE; TREATMENT OUTCOME;

EID: 1942532820     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2004.01.008     Document Type: Article

References (30)

1. Mailloux L.U., Levey A.S. Hypertension in patients with chronic renal disease. Am J Kid Dis. 32:(Suppl 3):1998;S120-S141.
2. Feld L.G., Lieberman E., Mendoza S.A., Springate J.E. Management of hypertension in the child with chronic renal disease. J Pediatr. 129:1996;S18-S26.
3. Soergel M., Schaefer F. Effect of hypertension on the progression of chronic renal failure in children. Am J Hypertens. 15:2002;53S-56S.
4. Mitsnefes M., Ho P.L., McEnery P.T. Hypertension and progression of chronic renal insufficiency in children a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). J Am Soc Nephrol. 14:2003;2618-2622.
5. Guidelines Committee. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. J Hypertens. 17:1999;151-183.
6. Ruilope L.M., Schiffrin E.L. Blood pressure control and benefits of antihypertensive therapy. Does it make a difference which agents we use? Hypertension. 38:2001;537-542.
7. Maschio G., Alberti D., Janin G., Locatelli F., Mann J.F.E., Motolese M., Ponticelli C., Ritz E., Zucchelli P. Effect of the angiotensin-converting- enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med. 334:1996;939-945.
8. GISEN Group. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet. 349:1997;1857-1863.
9. Cinotti G.A., Zucchelli P.C., Collaborative Study Group. Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies. Nephrol Dial Transplant. 16:2001;961-966.
10. Trachtmann H., Gauthier B. Effect of angiotensin converting enzyme inhibitor therapy on proteinuria in children with renal disease. J Pediatr. 112:1988;295-298.
11. Milliner D.S., Morgenstern B.Z. Angiotensin converting enzyme inhibitor for reduction of proteinuria in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 5:1991;587-590.
12. Proesmans W., van Wambeke I., van Dyck M. Long-term therapy with enalapril in patients with nephrotic-range proteinuria. Pediatr Nephrol. 10:1996;587-589.
13. Lama G., Salsano M.E., Pedulla M., Grassia C., Ruocco G. Angiotensin converting enzyme inhibitor and reflux nephropathy a 2 year follow-up. Pediatr Nephrol. 11:1997;714-719.
14. Sorof J.M., Portman R.J. Ambulatory blood pressure monitoring in the pediatric patient. J Pediatr. 16:2000;578-586.
15. Mansoor G.A. Ambulatory blood pressure monitoring in clinical trials in adults and children. Am J Hypertens. 15:2002;38S-42S.
16. Kaplan N.M., Sproul L.E., Mulcahy W.S. Large prospective study of ramipril in patients with hypertension. CARE Investigators. Clin Ther. 15:1993;810-818.
17. Smith W.H.T., Ball S.G. Ramipril. Int J Clin Pract. 54:2000;255-260.
18. Soergel M., Verho M., Wühl E., Gellermann J., Teichert L., Schärer K. Effect of ramipril on ambulatory blood pressure and albuminuria in renal hypertension. Pediatr Nephrol. 15:2000;113-118.
19. Hogg R.J., Furth S., Lemley K.V., Portman R., Schwartz G.J., Coresh J., Balk E., Lau J., Levin A., Kausz A.T., Eknoyan G., Levy A.S. National Kidney Foundation's kidney disease outcomes quality initiative clinical practice guidelines for chronic kidney disease in children and adolescents evaluation, classification, and stratification. Pediatrics. 111:2003;1416-1421.
20. Schwartz G.J., Brion L.P., Spitzer A. The use of plasma creatinine concentration to estimate glomerular filtration rate in infancy, childhood and adolescence. Pediatr Clin North Am. 34:1987;571-590.
21. Soergel M., Kirschstein M., Busch C., Danne T., Gellermann J., Holl R., Krull F., Reichert H., Reusz G.S., Rascher W. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents a multicenter trial including 1141 subjects. J Pediatr. 130:1997;178-184.
22. Seeman T., Šikut M., Konrad M., Vondřichová H., Janda J., Schärer K. Blood pressure and renal function in autosomal dominant polycystic kidney disease. Pediatr Nephrol. 11:1997;592-596.
23. Patzer L., Seeman T., Luck C., Wühl E., Janda J., Misselwitz J. Day- and nighttime blood pressure elevation in children with higher grades of renal scarring. J Pediatr. 142:2003;117-122.
24. Ecder T., Edelstein C.L., Fick-Brosnahan G.M., Johnson A.M., Chapman A.B., Gabow P.A., Schrier R.W. Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease. Am J Nephrol. 21:2001;98-103.
25. Ruggenenti P., Perna A., Mosconi L., Pisoni R., Remuzzi G. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. Kidney Int. 53:1998;1209-1216.
26. Jafar T.H., Stark P.C., Schmid C.H., Landa M., Maschio G., Marcantoni C., de Jong P.E., de Zeeuw D., Shahinfar S., Ruggenenti P., Remuzzi G., Levey A.S., AIPRD Study Group. Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int. 60:2001;1131-1140.
27. Remuzzi A., Fassi A., Bertani T., Perico A., Remuzzi G. ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy. Am J Kidney Dis. 34:1999;626-632.
28. Apperloo A.J., de Zeeuw D., de Jong P.E. Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease. Kidney Int. 45:(Suppl 45):1994;S174-S178.
29. Nosrati S.M., Khwaja S., El-Shahawy M., Massry S.G. Effect of angiotensin converting enzyme inhibition by perindopril on proteinuria of primary renal disease. Am J Nephrol. 17:1997;511-517.
30. Toto R.D., Adams-Huet B., Fenves A.Z., Mitchell H.C., Mulcahy W., Smith R.D. Effect of ramipril on blood pressure and protein excretion rate in normotensive nondiabetic patients with proteinuria. Am J Kidney Dis. 28:1996;832-840.